Pfizer Nurtec ODT Prescription Drugs Recall

Failure to Meet Child Resistant Packaging Requirement.

CPSC recall #23154 · announced Mar 16, 2023 · verified Jul 30, 2026

Hazard

The recalled prescription drugs must be in child resistant packaging as required by the Poison Prevention Packaging Act (PPPA). The packaging of the products is not child resistant, posing a risk of poisoning if the contents are swallowed by young children.

Remedy

Consumers should immediately secure the recalled product out of the sight and reach of children and contact Pfizer for a free child resistant pouch to store the product. Once the product is secured, consumers can continue to use it as directed.

Units

About 4.2 million

Pfizer Recalls Nurtec ODT Prescription Drugs Due to Failure to Meet Child Resistant Packaging Requirement; Risk of Poisoning

How to identify the recalled product

Product	Nurtec® ODT (rimegepant) orally disintegrating tablets, 75mg 8-Unit Dose blister pack
Manufacturer / importer	Biohaven Pharmaceuticals Inc., of New Haven, Conn.; Pfizer Inc., of New York
Units recalled	About 4.2 million

The recall

This recall involves prescription drugs Nurtec ODT 75 mg orally disintegrating tablets sold in cartons containing one blister card of 8 tablets. The tablets are in a non-child resistant blister card packaged in a carton that includes the name of the product, dosage strength, expiration date. The dosage strength and expiration date are printed or stamped on the blister card. The recall includes the following: Product Description NDC Number Expiration Date Nurtec® ODT (rimegepant) 75mg 8-Unit Dose blister pack 72618-3000-2 All dates through 6/2026

Reported incidents

None reported

What consumers should do now

Stop using the recalled product immediately. Contact the company for the announced remedy. Do not resell or donate recalled products — it is illegal under federal law.

Pfizer at 800-879-3477 Monday through Friday 9 a.m. to 7 p.m. ET, online at www.pfizer.com/contact or online at www.Nurtec.com/PackagingUpdate or www.Nurtec.com and click "Recall to provide child resistant pouches to patients for storage of their medicine. Click for details" for more information.

Source: U.S. Consumer Product Safety Commission. Official notice title: “Pfizer Recalls Nurtec ODT Prescription Drugs Due to Failure to Meet Child Resistant Packaging Requirement; Risk of Poisoning”. Read the official CPSC notice